• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与Gi1蛋白结合的G蛋白偶联受体HCAR1的结构揭示了配体识别和激动剂选择性的机制基础。

Structures of G-protein coupled receptor HCAR1 in complex with Gi1 protein reveal the mechanistic basis for ligand recognition and agonist selectivity.

作者信息

Pan Xin, Ye Fang, Ning Peiruo, Yu Yiping, Zhang Zhiyi, Wang Jingxuan, Chen Geng, Wu Zhangsong, Qiu Chen, Li Jiancheng, Chen Bangning, Zhu Lizhe, Qian Chungen, Gong Kaizheng, Du Yang

机构信息

Department of Cardiology, Institute of Cardiovascular Disease, Yangzhou Key Lab of Innovation Frontiers in Cardiovascular Disease, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.

Kobilka Institute of Innovative Drug Discovery, The Second Affiliated Hospital, Shenzhen Futian Biomedical Innovation R&D Center, School of Medicine, Chinese University of Hong Kong, Shenzhen, China.

出版信息

PLoS Biol. 2025 Apr 15;23(4):e3003126. doi: 10.1371/journal.pbio.3003126. eCollection 2025 Apr.

DOI:10.1371/journal.pbio.3003126
PMID:40233099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040280/
Abstract

Hydroxycarboxylic acid receptor 1 (HCAR1), also known as lactate receptor or GPR81, is a class A G-protein-coupled receptor with key roles in regulating lipid metabolism, neuroprotection, angiogenesis, cardiovascular function, and inflammatory response in humans. HCAR1 is highly expressed in numerous types of cancer cells, where it participates in controlling cancer cell metabolism and defense mechanisms, rendering it an appealing target for cancer therapy. However, the molecular basis of HCAR1-mediated signaling remains poorly understood. Here, we report four cryo-EM structures of human HCAR1 and HCAR2 in complex with the Gi1 protein, in which HCAR1 binds to the subtype-specific agonist CHBA (3.16 Å) and apo form (3.36 Å), and HCAR2 binds to the subtype-specific agonists MK-1903 (2.68 Å) and SCH900271 (3.06 Å). Combined with mutagenesis and cellular functional assays, we elucidate the mechanisms underlying ligand recognition, receptor activation, and G protein coupling of HCAR1. More importantly, the key residues that determine ligand selectivity between HCAR1 and HCAR2 are clarified. On this basis, we further summarize the structural features of agonists that match the orthosteric pockets of HCAR1 and HCAR2. These structural insights are anticipated to greatly accelerate the development of novel HCAR1-targeted drugs, offering a promising avenue for the treatment of various diseases.

摘要

羟基羧酸受体1(HCAR1),也被称为乳酸受体或GPR81,是一种A类G蛋白偶联受体,在调节人体脂质代谢、神经保护、血管生成、心血管功能和炎症反应中起关键作用。HCAR1在多种类型的癌细胞中高度表达,它在其中参与控制癌细胞代谢和防御机制,使其成为癌症治疗的一个有吸引力的靶点。然而,HCAR1介导的信号传导的分子基础仍知之甚少。在这里,我们报告了人HCAR1和HCAR2与Gi1蛋白复合物的四个冷冻电镜结构,其中HCAR1与亚型特异性激动剂CHBA(3.16 Å)和无配体形式(3.36 Å)结合,HCAR2与亚型特异性激动剂MK-1903(2.68 Å)和SCH900271(3.06 Å)结合。结合诱变和细胞功能测定,我们阐明了HCAR1的配体识别、受体激活和G蛋白偶联的潜在机制。更重要的是,明确了决定HCAR1和HCAR2之间配体选择性的关键残基。在此基础上,我们进一步总结了与HCAR1和HCAR2的正构口袋相匹配的激动剂的结构特征。这些结构见解有望极大地加速新型HCAR1靶向药物的开发,为治疗各种疾病提供一条有前景的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/1d60b60b5d52/pbio.3003126.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/536f6af1ff22/pbio.3003126.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/1cdec89cab60/pbio.3003126.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/0e95926e6806/pbio.3003126.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/5892ceb1f62a/pbio.3003126.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/b6889d294d1e/pbio.3003126.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/000f275f5216/pbio.3003126.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/1d60b60b5d52/pbio.3003126.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/536f6af1ff22/pbio.3003126.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/1cdec89cab60/pbio.3003126.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/0e95926e6806/pbio.3003126.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/5892ceb1f62a/pbio.3003126.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/b6889d294d1e/pbio.3003126.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/000f275f5216/pbio.3003126.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fb/12040280/1d60b60b5d52/pbio.3003126.g007.jpg

相似文献

1
Structures of G-protein coupled receptor HCAR1 in complex with Gi1 protein reveal the mechanistic basis for ligand recognition and agonist selectivity.与Gi1蛋白结合的G蛋白偶联受体HCAR1的结构揭示了配体识别和激动剂选择性的机制基础。
PLoS Biol. 2025 Apr 15;23(4):e3003126. doi: 10.1371/journal.pbio.3003126. eCollection 2025 Apr.
2
Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3.人源羟酸受体 HCAR3 配体识别的结构基础。
Cell Rep. 2024 Nov 26;43(11):114895. doi: 10.1016/j.celrep.2024.114895. Epub 2024 Oct 19.
3
Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.关于人类羟基羧酸受体HCAR2的配体识别和选择性的结构见解。
Cell Discov. 2023 Nov 28;9(1):118. doi: 10.1038/s41421-023-00610-7.
4
Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2.羟基羧酸受体 2 的配体识别和信号转导的结构基础。
Nat Commun. 2023 Nov 6;14(1):7150. doi: 10.1038/s41467-023-42764-8.
5
Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.人源羟羧酸受体 2 对烟酸和降脂药物的分子识别。
Cell Rep. 2023 Nov 28;42(11):113406. doi: 10.1016/j.celrep.2023.113406. Epub 2023 Nov 11.
6
Structural insights into endogenous ligand selectivity and activation mechanisms of FFAR1 and FFAR2.对游离脂肪酸受体1(FFAR1)和游离脂肪酸受体2(FFAR2)的内源性配体选择性及激活机制的结构见解。
Cell Rep. 2024 Dec 24;43(12):115024. doi: 10.1016/j.celrep.2024.115024. Epub 2024 Nov 30.
7
Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.羟酸受体 HCAR2 的变构配体选择性和变构探针依赖性。
Signal Transduct Target Ther. 2023 Sep 25;8(1):364. doi: 10.1038/s41392-023-01625-y.
8
The Lactate Receptor HCAR1 Modulates Neuronal Network Activity through the Activation of G and G Subunits.乳酸受体 HCAR1 通过激活 G 和 G 亚基调节神经元网络活动。
J Neurosci. 2019 Jun 5;39(23):4422-4433. doi: 10.1523/JNEUROSCI.2092-18.2019. Epub 2019 Mar 29.
9
Orthosteric and allosteric modulation of human HCAR2 signaling complex.人源 HCAR2 信号复合物的变构调节和变构调节。
Nat Commun. 2023 Nov 22;14(1):7620. doi: 10.1038/s41467-023-43537-z.
10
Bitter taste TAS2R14 activation by intracellular tastants and cholesterol.苦味味觉受体 TAS2R14 被细胞内味觉配体和胆固醇激活。
Nature. 2024 Jul;631(8020):459-466. doi: 10.1038/s41586-024-07569-9. Epub 2024 May 22.

本文引用的文献

1
Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3.人源羟酸受体 HCAR3 配体识别的结构基础。
Cell Rep. 2024 Nov 26;43(11):114895. doi: 10.1016/j.celrep.2024.114895. Epub 2024 Oct 19.
2
Structural basis for the ligand recognition and G protein subtype selectivity of kisspeptin receptor.促黄体激素释放素受体配体识别和 G 蛋白亚型选择性的结构基础。
Sci Adv. 2024 Aug 16;10(33):eadn7771. doi: 10.1126/sciadv.adn7771.
3
Activation of GPR81 by lactate drives tumour-induced cachexia.乳酸激活 GPR81 驱动肿瘤诱导的恶病质。
Nat Metab. 2024 Apr;6(4):708-723. doi: 10.1038/s42255-024-01011-0. Epub 2024 Mar 18.
4
Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution.通过单氨基酸取代对人烟酸受体中偏向激动作用进行结构导向工程改造。
Nat Commun. 2024 Mar 2;15(1):1939. doi: 10.1038/s41467-024-46239-2.
5
Structural basis for the ligand recognition and signaling of free fatty acid receptors.游离脂肪酸受体配体识别和信号转导的结构基础。
Sci Adv. 2024 Jan 12;10(2):eadj2384. doi: 10.1126/sciadv.adj2384. Epub 2024 Jan 10.
6
Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3.短链脂肪酸受体FFAR2/3的分子识别与激活机制
Cell Res. 2024 Apr;34(4):323-326. doi: 10.1038/s41422-023-00914-z. Epub 2024 Jan 9.
7
Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.关于人类羟基羧酸受体HCAR2的配体识别和选择性的结构见解。
Cell Discov. 2023 Nov 28;9(1):118. doi: 10.1038/s41421-023-00610-7.
8
Orthosteric and allosteric modulation of human HCAR2 signaling complex.人源 HCAR2 信号复合物的变构调节和变构调节。
Nat Commun. 2023 Nov 22;14(1):7620. doi: 10.1038/s41467-023-43537-z.
9
Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.人源羟羧酸受体 2 对烟酸和降脂药物的分子识别。
Cell Rep. 2023 Nov 28;42(11):113406. doi: 10.1016/j.celrep.2023.113406. Epub 2023 Nov 11.
10
Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2.羟基羧酸受体 2 的配体识别和信号转导的结构基础。
Nat Commun. 2023 Nov 6;14(1):7150. doi: 10.1038/s41467-023-42764-8.